07:00 , Mar 26, 2012 |  BC Week In Review  |  Financial News

Boston Therapeutics financial update

Boston Therapeutics (formerly Avanyx Therapeutics Inc. ) listed on the OTC Bulletin Board without raising money under the symbol "BTHE." Boston Therapeutics Inc. (OTCBB:BTHE), Manchester, N.H.   Business: Endocrine/Metabolic, Inflammation, Chemistry   Date announced: 3/22/12...
07:00 , Mar 12, 2012 |  BC Week In Review  |  Financial News

Boston Therapeutics financial update

Boston Therapeutics (formerly Avanyx Therapeutics Inc. ) said it was cleared to list on the OTC Bulletin Board without raising money under the ticker symbol "BTHE." No date or price has been set. Boston Therapeutics...
07:00 , Oct 4, 2010 |  BioCentury  |  Finance

4Q Financial Markets Preview: Watershed moment

If biotech companies hit their milestones this quarter, the resulting stock upticks and opportunities to raise money could support both companies and investors for years. On the other hand, if things go wrong, generalists could...
07:00 , Sep 27, 2010 |  BC Week In Review  |  Financial News

Avanyx Therapeutics amends IPO

Avanyx Therapeutics Inc. , Newton, Mass.   Business: Cardiovascular, Veterinary   Date announced: 9/20/10   Type: IPO   To be raised: Up to $15 million   Shares: 15 million   Price: TBD   Shares after...
00:47 , Sep 21, 2010 |  BC Extra  |  Financial News

Avanyx amends IPO

Avanyx Therapeutics Inc. (Newton, Mass.) amended its IPO and now hopes to raise up to $15 million through the sale of 15 million shares at $1. The price would value the company at $25 million....
07:00 , Jul 5, 2010 |  BioCentury  |  Finance

3Q Financial Markets Preview: Summer scrapes bottom

Biotech indices may be mostly back to or even below where they started the year, but investors aren't in a hurry to do bottom fishing over the summer. Instead, they are hopeful biotech's bad breaks...
07:00 , Apr 5, 2010 |  BioCentury  |  Finance

2Q Financial Markets Preview: Wanted Dry Powder

Biotech run-ups have historically cooled after 25-30% gains. Thus the question going into the second quarter is whether there's momentum to keep going, or whether the sector will take a breather. The historical numbers are...
08:00 , Feb 15, 2010 |  BC Week In Review  |  Financial News

Avanyx Therapeutics proposes IPO

Avanyx Therapeutics Inc. , Newton, Mass.   Business: Cardiovascular, Veterinary   Date announced: 2/8/10   Type: IPO   To be raised: Up to $30 million   Shares: 15 million   Price: $2   Shares after...
08:00 , Feb 15, 2010 |  BioCentury  |  Finance

Small fry

Last week, one small, non-underwritten IPO made it out, while another was filed. Australian autoimmune and inflammatory disease company CBio Ltd. (ASX:CBZ) raised A$7.1 million ($6.2 million) through the sale of 7.1 million shares at...
01:48 , Feb 9, 2010 |  BC Extra  |  Financial News

Avanyx files for IPO

Avanyx Therapeutics Inc. (Newton, Mass.) filed to raise up to $30 million through the sale of up to 15 million shares at $2 in an IPO. The offering is not underwritten. A $2 price would...